ITSCC MEMBER MEETING
Saturday, March 20, 2021
|12:00 – 12:05 pm||Opening remarks by ITSCC President, Sarah Arron, MD|
|12:05 – 12:50 pm||Abstracts and Educational Session|
|12:50 – 1:10 pm||Business Meeting|
|1:10 – 1:55 pm||Keynote speaker - Oscar Colegio Memorial Lecture
Dr. Catherine Harwood, MA, PhD, FRCP; Professor of Dermatology,
Royal London Hospital and Blizzard Institute, Queen Mary University of London
|1:55 – 2:05 pm||NCCN Update, Chrys Schmults, MD|
|2:05 - 2:40 pm||Tumor Board|
|2:40 – 2:45 pm||Closing Remarks|
|2:45 – 3:15 pm||Zoom Pictionary|
Castle Biosciences, Inc.
820 S. Friendswood Dr., Suite 201
Friendswood, TX 77546
P (866) 788-9007
Castle Biosciences is a skin cancer diagnostics company focused on providing physicians and patients with personalized, clinically actionable genomic information enabling more accurate treatment plan decisions. From its formation in 2008, Castle Biosciences has applied emerging artificial intelligence techniques in molecular diagnostics to improve patient care and outcomes. Our DecisionDx family of molecular diagnostic tests have the ability to meaningfully impact how cancers are diagnosed and managed (https://castletestinfo.com).
1 DNA Way
South San Francisco, CA 94080
P (650) 255-2169
For more than 40 years, we've been following the science, seeking solutions to unmet medical needs. As a proud member of the Roche Group, we make medicines to treat patients with serious medical conditions.
2020 ITSCC Member Meeting
Thursday, March 19, 2020
VIDEO: 2020 ITSCC Meeting
2019 ITSCC Annual Member Meeting
Thursday, February 28, 2019
The National Press Club
529 14th Street NW, 13th Floor
Washington, DC, USA
2018 ITSCC Retreat
Thursday, September 27 – Sunday, September 30, 2018
Essex Conference & Retreat Center
Essex, Massachusetts, USA
ITSCC at the International Investigative Dermatology (IID) 2018 Meeting
Thursday, May 17, 2018
6:00 – 7:30 pm
Panzacola Room G1
Rosen Shingle Creek Resort
Orlando, Florida, USA
Visit the IID website
2018 ITSCC Member Meeting at the AAD
Thursday, February 15, 2018
5:30 – 8:30 pm
San Diego, California, USA
The Ultimate Skybox at Diamond View
350 Tenth Ave., San Diego, CA 92101
Program Director: Seaver Soon, MD
ITSCC members came together for a scientific program during the AAD meeting in San Diego. The educational session started with a brief business meeting followed by presentations and a Tumor Board focused on immunotherapy.
ITSCC Transplant Dermatology Symposium at SID 2017
ITSCC colleagues joined together for the second annual ITSCC Transplant Dermatology Symposium on Thursday, April 27 at the annual meeting of the Society for Investigative Dermatology in Portland, Oregon. The symposium was directed by Oscar Colegio, MD, PhD. Four oral abstracts were presented at this Symposium:
- Genomic analysis reveals drivers of high-risk subsets of cutaneous squamous cell carcinoma
- Tran Nguyen, H. Lee Moffitt Cancer Center & Research Institute, Kimal Rajapakshe, Baylor College of Medicine, Vida Chitsazzadeh, University of Texas Health Sciences Center Houston, Kimberly Truong, H. Lee Moffitt Cancer Center & Research Institute, Chrysalyne Schmults, Harvard Medical School, AP South, TJU, Raymond Cho, University of California, San Francisco, Cristian Coarfa, Baylor College of Medicine, K Tsai, RDEB SCC Sequencing Consortium.
- Risk factors of high frequency basal cell carcinoma: Gender, histologic subtypes, anatomic distribution, and associated immunosuppression
- Karen Kuo, Stanford University School of Medicine, Hyunje Cho, Stanford University School of Medicine, Prag Batra, Stanford University School of Medicine, Shufeng Li, Stanford University School of Medicine, Kerri Rieger, Stanford Dermatology, Jean Tang, Stanford University, Kavita Sarin, Stanford University.
- Cutaneous infection rates are not affected by chronic HIV(+) or HCV(+) coinfection in organ transplant recipients
- Kumar Nadhan, Drexel Dermatology, Scott Shipman, Drexel Dermatology, Erin Buchanan, Drexel Dermatology, Gregory Malat, Drexel Surgery, Alden Doyle, University of Virginia, Christina Chung, Drexel Dermatology
- IL-22 promotes early aggressive behavior of cutaneous squamous cell carcinoma (SCC); A murine xenograft model
- Melody Abikhair, Dept of Derm, NYU Langone Med Ctr, Nazanin Roudiani, Dept of Derm, NYU Langone Med Ctr, Alexis Santana, Dept of Derm, NYU Langone Med Ctr, Jie Chen, Inst for Ped Urol, Weill Cornell Medicine, Diane Felsen, Inst for Ped Urol, Weill Cornell Medicine, John Carucci, Dept of Derm, NYU Langone Med Ctr.
Congrats to all on a successful event.
(L-R) Christina Chung, Oscar Colegio, Melody Abikhair, Tran Nguyen, Karen Kuo.
ITSCC Members Present “Topics in Transplant” at ACMS Annual Meeting
ITSCC Past President Fiona Zwald, MD, MRCPI moderated a session, “Topics in Transplant from ITSCC” at the 2017 Annual Meeting of the American College of Mohs Surgery at the Hilton San Francisco Union Square on Saturday, April 29.
Zwald and speakers Matthew Fox, MD and Justin Leitenberger, MD discussed the importance of obtaining a medical and drug history in the evaluation of an immunosuppressed patient who presents with an aggressive skin cancer; description of pre-op and post-op management of aggressive skin cancer in immunosuppressed patients; and use of adjuvant therapies in the immunosuppressed patient with skin cancer.
(L-R) Justin Leitenberger, MD; Fiona Zwald, MD; Matthew Fox, MD
Your tax-deductible donation supports the education and research of physicians and scientists committed to improving the quality of life of organ transplant recipients. If you are unable to donate online or require other information to make a gift through a trust or other source, email email@example.com for additional assistance. ITSCC's federal tax ID is 43-1964114.
ITSCC is a nonprofit 501(c)(3) organization, and has received support through unrestricted educational grants from pharmaceutical companies and donations of time and funds from physicians, researchers, transplant patients and their families.